Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/02 | 1,334 | 1,395 | 1,295 | 1,320 | -32 | -2.4% | 133,500 |
2021/12/01 | 1,255 | 1,380 | 1,203 | 1,352 | +111 | +8.9% | 135,300 |
2021/11/30 | 1,283 | 1,315 | 1,232 | 1,241 | +27 | +2.2% | 74,400 |
2021/11/29 | 1,213 | 1,278 | 1,195 | 1,214 | -26 | -2.1% | 56,200 |
2021/11/26 | 1,254 | 1,272 | 1,207 | 1,240 | -19 | -1.5% | 59,400 |
2021/11/25 | 1,258 | 1,314 | 1,245 | 1,259 | -10 | -0.8% | 50,000 |
2021/11/24 | 1,303 | 1,303 | 1,257 | 1,269 | -48 | -3.6% | 44,200 |
2021/11/22 | 1,321 | 1,323 | 1,271 | 1,317 | -6 | -0.5% | 56,100 |
2021/11/19 | 1,365 | 1,366 | 1,319 | 1,323 | -42 | -3.1% | 29,900 |
2021/11/18 | 1,375 | 1,382 | 1,317 | 1,365 | +2 | +0.1% | 52,700 |
2021/11/17 | 1,410 | 1,418 | 1,351 | 1,363 | -47 | -3.3% | 75,000 |
2021/11/16 | 1,318 | 1,425 | 1,310 | 1,410 | +92 | +7% | 106,500 |
2021/11/15 | 1,261 | 1,336 | 1,230 | 1,318 | +65 | +5.2% | 119,500 |
2021/11/12 | 1,113 | 1,309 | 1,070 | 1,253 | +149 | +13.5% | 208,800 |
2021/11/11 | 1,138 | 1,145 | 1,101 | 1,104 | -28 | -2.5% | 37,700 |
2021/11/10 | 1,124 | 1,149 | 1,097 | 1,132 | +1 | +0.1% | 61,500 |
2021/11/09 | 1,219 | 1,234 | 1,116 | 1,131 | -87 | -7.1% | 211,700 |
2021/11/08 | 1,230 | 1,266 | 1,208 | 1,218 | -9 | -0.7% | 58,300 |
2021/11/05 | 1,232 | 1,241 | 1,189 | 1,227 | ±0 | ±0% | 71,600 |
2021/11/04 | 1,300 | 1,302 | 1,220 | 1,227 | -43 | -3.4% | 54,100 |
2021/11/02 | 1,228 | 1,295 | 1,228 | 1,270 | +35 | +2.8% | 54,300 |
2021/11/01 | 1,226 | 1,250 | 1,208 | 1,235 | +28 | +2.3% | 37,200 |
2021/10/29 | 1,206 | 1,222 | 1,179 | 1,207 | +10 | +0.8% | 59,600 |
2021/10/28 | 1,185 | 1,208 | 1,174 | 1,197 | -2 | -0.2% | 20,600 |
2021/10/27 | 1,208 | 1,208 | 1,179 | 1,199 | -1 | -0.1% | 9,200 |
2021/10/26 | 1,142 | 1,209 | 1,142 | 1,200 | +52 | +4.5% | 40,500 |
2021/10/25 | 1,142 | 1,159 | 1,125 | 1,148 | -9 | -0.8% | 32,500 |
2021/10/22 | 1,152 | 1,173 | 1,133 | 1,157 | +5 | +0.4% | 38,000 |
2021/10/21 | 1,189 | 1,192 | 1,140 | 1,152 | -37 | -3.1% | 89,700 |
2021/10/20 | 1,190 | 1,215 | 1,180 | 1,189 | -18 | -1.5% | 34,000 |
2021/10/19 | 1,194 | 1,221 | 1,186 | 1,207 | +7 | +0.6% | 20,000 |
2021/10/18 | 1,235 | 1,236 | 1,197 | 1,200 | -39 | -3.1% | 30,200 |
2021/10/15 | 1,217 | 1,239 | 1,209 | 1,239 | +31 | +2.6% | 25,200 |
2021/10/14 | 1,170 | 1,208 | 1,157 | 1,208 | +31 | +2.6% | 32,000 |
2021/10/13 | 1,187 | 1,200 | 1,170 | 1,177 | -16 | -1.3% | 30,800 |
2021/10/12 | 1,230 | 1,230 | 1,191 | 1,193 | -32 | -2.6% | 49,500 |
2021/10/11 | 1,198 | 1,225 | 1,169 | 1,225 | +27 | +2.3% | 47,800 |
2021/10/08 | 1,210 | 1,244 | 1,190 | 1,198 | -2 | -0.2% | 86,300 |
2021/10/07 | 1,152 | 1,216 | 1,146 | 1,200 | +54 | +4.7% | 79,000 |
2021/10/06 | 1,181 | 1,200 | 1,124 | 1,146 | -19 | -1.6% | 99,900 |
2021/10/05 | 1,172 | 1,190 | 1,147 | 1,165 | -37 | -3.1% | 125,900 |
2021/10/04 | 1,275 | 1,280 | 1,200 | 1,202 | -63 | -5% | 134,000 |
2021/10/01 | 1,247 | 1,330 | 1,247 | 1,265 | -12 | -0.9% | 85,800 |
2021/09/30 | 1,266 | 1,295 | 1,243 | 1,277 | +4 | +0.3% | 71,900 |
2021/09/29 | 1,241 | 1,273 | 1,241 | 1,273 | +3 | +0.2% | 46,100 |
2021/09/28 | 1,299 | 1,299 | 1,265 | 1,270 | -22 | -1.7% | 32,200 |
2021/09/27 | 1,318 | 1,337 | 1,292 | 1,292 | -28 | -2.1% | 80,000 |
2021/09/24 | 1,296 | 1,335 | 1,295 | 1,320 | +54 | +4.3% | 60,100 |
2021/09/22 | 1,287 | 1,316 | 1,243 | 1,266 | -34 | -2.6% | 115,400 |
2021/09/21 | 1,293 | 1,319 | 1,285 | 1,300 | -40 | -3% | 61,500 |
601~
650
件表示中 / 1363件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 58,800円 | - | - | 0.00% | - | 3.93倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
カイノス | 114,800円 | +6.8% | -13.8% | 2.79% | 8.80倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
キッズバイオ | 13,000円 | - | - | 0.00% | - | 7.57倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
ソレイジア | 2,600円 | +102.6% | - | 0.00% | - | 2.52倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
免疫生物 | 50,300円 | +13.4% | -4.0% | 0.00% | 40.73倍 | 3.70倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
市場注目の銘柄
チャート関連のコラム